News

Array ( [0] => stdClass Object ( [id] => 1378 [id_crawler] => [category_product] => NULL [thumbnail] => 48be86a032fdbea3e7ec.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2025-11-03 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-11-03 10:24:41 [updated_time] => 2025-11-21 10:13:42 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => Eurofins-GENTIS-accompanies-the-25th-Vietnam-France-obstetrics-and-gynecology-conference-2025 [title] => Eurofins GENTIS accompanies the 25th Vietnam–France obstetrics and gynecology conference (2025) [description] => Amid the dynamic collaboration between Vietnam and France in the field of medicine, the 25th Vietnam–France Obstetrics and Gynecology Conference will officially take place on November 9–10, 2025, in Hanoi. This prestigious annual scientific event in obstetrics and gynecology is hosted by the National Hospital of Obstetrics and Gynecology (NHOG) in collaboration with the French National College of Gynecologists and Obstetricians (CNGOF). [content] =>

This year’s conference marks 25 years of effective cooperation between the two nations in training, research, and the transfer of medical advances—aiming to improve reproductive healthcare quality and contribute to the protection and development of the Vietnamese population.

With 1,500 delegates attending onsite and another 1,000 participating online, the conference gathers leading scientists, physicians, and specialists from Vietnam, France, and many other countries. It serves as an important academic platform for experts to exchange and update the latest knowledge in obstetrics, gynecology, assisted reproduction, and medical genetics.

Eurofins GENTIS – Sponsoring Partner of the 2025 Vietnam–France Obstetrics and Gynecology Conference

With the mission “Enhancing the Intellectual and Physical Well-being of Vietnamese People,” Eurofins GENTIS is honored to accompany the 25th Vietnam–France Obstetrics and Gynecology Conference as a sponsor. Our presence at the event reflects not only our spirit of cooperation and commitment to the medical community but also our dedication to promoting the scientific value and practical application of genetic testing in reproductive healthcare.

Over the past 15 years, Eurofins GENTIS has become a pioneer in genetic testing in Vietnam, operating a network of laboratories accredited by CAP and ISO 15189:2022, and supported by leading domestic and international scientific advisors. GENTIS provides genetic testing services that serve individuals and families while also supporting obstetricians and gynecologists in diagnosis, pregnancy monitoring, and the management of reproductive health issues.

GENTIS Booth – A Genetic Technology Highlight at the Conference

At this year’s Vietnam–France Obstetrics and Gynecology Conference, Eurofins GENTIS introduces an exhibition and consultation booth where delegates can explore comprehensive genetic testing solutions.

Featured services include:

NIPT (Non-invasive Prenatal Testing) for early detection of chromosomal abnormalities in fetuses from week 9.

Preimplantation Genetic Testing (PGT) to support IVF centers in selecting healthy embryos, increasing pregnancy rates, and improving birth outcomes.

Genetic disease carrier testing, enabling the detection of recessive gene carriers and providing premarital and preconception counseling.

Andrology testing to support diagnosis and treatment in male fertility.

In addition to showcasing technologies and services, the GENTIS team will be present to answer questions and offer expert consultation to physicians, researchers, and attendees. The Eurofins GENTIS booth is designed with a modern, open layout, creating a friendly and effective space for discussion.

Exciting Minigame – Connect with GENTIS and Receive Instant Gifts

To bring a more engaging and interactive experience to delegates, Eurofins GENTIS is hosting an interactive minigame at our booth throughout the conference.

With simple participation steps, visitors can join quick interactive activities or answer questions related to genetics and reproductive health to receive meaningful and surprising gifts from GENTIS.

Beyond entertainment, the minigame serves as a bridge to help physicians, scientists, and guests better understand the vital role of genetics in modern medicine—from prenatal screening and assisted reproduction to community genetic counseling.

Through these approachable activities, GENTIS aims to spread the message:
“Genetics is not distant—it is a companion in every family’s reproductive healthcare journey.”

Supporting the Advancement of Obstetrics and Gynecology in Vietnam

In recent years, cooperation between Vietnam and France in obstetrics and gynecology has achieved remarkable progress. The conference is not only a platform for academic exchange but also a venue for connecting institutions, hospitals, enterprises, and research centers to promote the application of advanced science in clinical practice.

GENTIS is proud to be part of this journey. By continuously investing in technology, enhancing professional quality, and expanding international cooperation, we aim to bring advanced genetic testing closer to Vietnamese people and support healthcare professionals in diagnosing, treating, and preventing genetic diseases.

GENTIS – A Trusted Partner in Medical Genetics

With core values of “Integrity, Innovation, Dedication, Respect, and Continuous Learning,” Eurofins GENTIS has become a trusted partner of hundreds of hospitals, IVF centers, and healthcare institutions nationwide. Our products, services, and research initiatives are designed to enhance population health, support safe and effective reproduction, and align with Vietnam’s comprehensive healthcare orientation.

Our sponsorship of the 2025 Vietnam–France Obstetrics and Gynecology Conference demonstrates our commitment to sharing knowledge, creating value, and contributing to the modernization of Vietnamese medicine toward international standards.

The 25th Vietnam–France Obstetrics and Gynecology Conference promises to be one of the most significant scientific events of 2025, opening new directions in research, collaboration, and application in reproductive healthcare.

Eurofins GENTIS warmly invites physicians, specialists, and delegates to visit the GENTIS booth to explore advanced genetic solutions, update new trends, and participate in our exciting minigame for a chance to receive special gifts.

[content_more] => [meta_title] => Eurofins GENTIS accompanies the 25th Vietnam–France obstetrics and gynecology conference (2025) [meta_description] => Amid the dynamic collaboration between Vietnam and France in the field of medicine, the 25th Vietnam–France Obstetrics and Gynecology Conference will officially take place on November 9–10, 2025, in Hanoi. [meta_keyword] => GENTIS [thumbnail_alt] => [post_id] => 1378 [category_id] => 4 ) [1] => stdClass Object ( [id] => 1377 [id_crawler] => [category_product] => NULL [thumbnail] => a726c71514489816c159.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2025-11-03 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-11-03 10:17:32 [updated_time] => 2025-11-21 10:22:11 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => GENTIS-welcomes-the-delegation-from-Orienda-international-hospital [title] => GENTIS welcomes the delegation from Orienda International hospital [description] => On November 1, 2025, Eurofins GENTIS had the honor of welcoming a delegation from Orienda International Hospital (Phnom Penh, Cambodia) to visit and work at the company headquarters. The visit was part of an international cooperation program designed to enhance professional exchange, share experiences, and expand development opportunities in reproductive medicine and laboratory testing between the two organizations. [content] =>

The delegation from Orienda International Hospital included Mr. Leangseng – Head of Laboratory Department and Dr. Chhit Maryan. Representing Eurofins GENTIS were Mr. Nguyen Van Huynh – R&D Team Leader, Dr. Vu Thu Huong – R&D Specialist, and Ms. Le Thi Thuy Hang – International Cooperation Coordinator.

The working session took place in an open, warm, yet professional atmosphere, reflecting the shared mission of both organizations: to elevate the quality of reproductive healthcare in Southeast Asia.

Orienda International Hospital – A Leading Private Healthcare Institution in Phnom Penh

Orienda International Hospital is one of the leading private hospitals in Phnom Penh, Cambodia, built to international standards with a total investment of over 20 million USD. Developed as a multidisciplinary international hospital, Orienda emphasizes not only medical expertise but also patient experience—creating a safe, modern, and patient-centered environment.

The hospital is equipped with advanced and synchronized medical infrastructure, meeting strict requirements for examination, treatment, and healthcare services. Orienda offers a wide range of medical services, including:

Obstetrics and Gynecology, particularly maternity care and assisted reproduction

Pediatrics, with neonatal treatment services at the NICU

Intensive Care (ICU) and Diagnostic Imaging, improving diagnostic and treatment capabilities

With a team of physicians and healthcare specialists from Cambodia, Singapore, and several other countries, Orienda aims to deliver international-standard medical services to Cambodian citizens and the international community living and working there.

As part of its development strategy, Orienda places strong emphasis on cooperation with international partners in laboratory testing and biotechnology to enhance expertise and adopt modern diagnostic technologies. Therefore, this visit to Eurofins GENTIS carries significant meaning in fostering collaboration, learning, and expanding partnership opportunities.

In-Depth Technical Exchange at Eurofins GENTIS Headquarters

During the working session, the two sides engaged in in-depth discussions on reproductive laboratory technologies, including pre- and post-implantation genetic testing solutions, embryo screening techniques, and gene-based analyses supporting infertility treatment.

The GENTIS R&D team presented an overview of the company’s comprehensive genetic testing ecosystem, including several pioneering services in Vietnam and Southeast Asia such as:

Preimplantation Genetic Testing (PGT) for early detection of chromosomal abnormalities in embryos

Premarital and preconception genetic carrier screening, supporting early detection of hereditary disorders

Genetic tests for assisted reproduction, helping optimize treatment protocols and improve success rates for infertile couples

Following the presentation, the Orienda delegation toured the Eurofins GENTIS laboratories, where stringent quality management procedures are implemented based on international standards of Eurofins Scientific. The Orienda experts expressed high appreciation for GENTIS’s testing capabilities, laboratory technologies, and well-trained personnel.

Toward Strategic Cooperation for the Future

The working session was not only an opportunity for both sides to share expertise and experience in genetic testing, but also opened potential for strategic collaboration in the near future.

Eurofins GENTIS and Orienda International Hospital agreed to pursue common goals:

Enhancing healthcare service quality

Expanding access to advanced genetic testing technologies throughout Southeast Asia

This connection is expected to lay the foundation for joint training programs, collaborative research, and technology transfer in genetic testing.

In the coming period, GENTIS and Orienda plan to continue regular professional exchanges and explore specific collaborative projects in assisted reproduction, genetic diagnostics, and workforce training. Both organizations anticipate that this cooperation will facilitate greater access to high-tech medical innovations for physicians and patients in Cambodia, while strengthening Vietnam’s position as a regional leader in medical genetics.

A Milestone in International Cooperation

The working session between Eurofins GENTIS and Orienda International Hospital marks a new step forward in international collaboration and reflects GENTIS’s vision of connecting global scientific knowledge to improve human life. GENTIS remains committed to investing in research, technological advancement, and global partnerships—contributing sustainable value to the community for a healthier, happier future.

[content_more] => [meta_title] => GENTIS welcomes the delegation from Orienda International hospital [meta_description] => On November 1, 2025, Eurofins GENTIS had the honor of welcoming a delegation from Orienda International Hospital (Phnom Penh, Cambodia) to visit and work at the company headquarters. [meta_keyword] => [thumbnail_alt] => [post_id] => 1377 [category_id] => 4 ) [2] => stdClass Object ( [id] => 1376 [id_crawler] => [category_product] => NULL [thumbnail] => 600x400-web-gentis-15-nam.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2025-10-26 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-10-28 08:55:32 [updated_time] => 2025-10-29 10:00:15 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => GENTIS-15-years-sowing-aspirations-reaping-trust [title] => GENTIS 15 Years – sowing aspirations, reaping trust [description] => On October 26, 2010, a small milestone was marked in the field of biomedical science in Vietnam: GENTIS – the first genetic testing center in Hanoi – was founded. Few knew that from this modest beginning, a 15-year journey of perseverance and dedication to the mission “Enhancing the Physical and Intellectual Health of Vietnamese People” would unfold, built on trust, knowledge, and resilience to overcome every challenge. [content] =>

From first steps to remarkable achievements in genetics

Starting in Hanoi with the aspiration to “pioneer the field of genetics,” GENTIS was among the first institutions in Vietnam to introduce access to genetic science – a technology largely unfamiliar to most people at that time. Driven by strong faith in the future, within just three years, GENTIS opened a branch in Ho Chi Minh City, marking the first step in bringing the world’s most advanced genetic technology closer to Vietnamese people.

In 2015, GENTIS became the first DNA laboratory in Vietnam to achieve ISO 9001:2015 certification, with its testing systems built according to the recommendations of the U.S. FBI. This was not only an achievement but a strong affirmation of GENTIS’s commitment to quality and international standards as the foundation for its development.

Continuing its growth, in 2017 GENTIS expanded into oncology and infectious disease testing. By 2018, GENTIS reached the international stage as an official partner of Illumina (USA), the world leader in gene sequencing.

From 2019 to 2020, GENTIS focused on providing genetic analysis solutions to support reproductive health and comprehensive healthcare, consistently placing people at the center of every development strategy.

In 2021, the Covid-19 pandemic posed a significant test for the healthcare sector, and GENTIS stepped up. The company became one of the few private healthcare facilities certified for SARS-CoV-2 testing, collaborating with Hanoi CDC on large-scale community testing campaigns. GENTIS staff worked tirelessly on the front lines, collecting samples and running tests, contributing to the protection of millions of people across the country.

In 2022, GENTIS officially became a member of Eurofins – the world’s leading medical group – marking a historic turning point and elevating GENTIS to an international brand. This was not just a legal merger but a complete transformation in processes, personnel, mindset, and technology.

Building on this success, in 2024 Eurofins – GENTIS inaugurated a new, modern 2,000 m² headquarters in central Hanoi, a significant step in both scale and readiness to meet the growing and increasingly complex testing needs of domestic and international clients.

GENTIS hosts CAP expert delegation to evaluate Hanoi laboratory

After more than a year of relentless effort, hundreds of strict criteria, and thousands of hours of quality inspections, in June 2025, Eurofins – GENTIS became the pioneering unit in Vietnam to achieve CAP certification for two core genetic tests: PGT and NIPT. For the first time, a genetic testing facility in Vietnam was recognized internationally at the highest level for quality and expertise in the two most advanced techniques in reproductive support and prenatal screening. This achievement was not only GENTIS’s success but also a step forward for Vietnam’s biomedical industry on the global map.

Raising the standards of Vietnamese genetic medicine

GENTIS has contributed not only to its own growth but also to the advancement of Vietnam’s biomedical sector. Deep genetic tests, which previously had to be sent abroad at high costs, can now be performed domestically with equivalent quality. As shared by Assoc. Prof. Dr. Nguyen Dinh Tao, Chairman of the Hanoi Association for Reproductive Support: “GENTIS participates in conferences, workshops, and scientific activities both in-person and online. With its professional expertise, personnel, and advanced medical equipment and technology, GENTIS has helped introduce modern genetic testing technologies in Vietnam, particularly in reproductive support.”

Prof. Tao added: “Previously, many genetic tests for reproductive support had to be done overseas at high costs. Now, units like GENTIS have applied advanced technology and equipment locally, playing a crucial role in developing Vietnam’s reproductive support sector and improving success rates. As a result, infertile couples, including overseas Vietnamese, can now return to Vietnam for reproductive support services.”

Moreover, GENTIS actively collaborates with hospitals, universities, and international organizations to bring applied scientific value closer to the Vietnamese medical community.

Linking business growth with social responsibility

Beyond professional development, GENTIS pursues community initiatives, such as:

Providing free DNA testing to help issue birth certificates for children in special circumstances
Donating testing kits and supporting frontline staff during the Covid-19 pandemic
Offering free HPV-DNA tests for women in Phu Ninh District
Giving newborn clothes and teddy bears to hundreds of new mothers at Thanh Nhan Hospital
Donating and supporting Central Vietnam communities affected by floods and storms
Awarding scholarships in genetic biomedical studies to talented students at Hanoi Medical University
In 2025, in partnership with Dantri newspaper, GENTIS provided DNA tests for family reunification, helping four families reconnect after years apart – a journey of restoring love through the power of science.

People – the heart of every achievement

Over 15 years, equipment and technology may evolve, but the soul of GENTIS lies in its people. From resident doctors, R&D specialists, project managers, sample collectors, lab technicians, business and customer care staff, to HR, accounting, marketing, legal, ISO, and procurement teams – all are professionally trained, continuously updating their knowledge and skills.

GENTIS leadership recognizes that quality is the company’s core value, and thus has built a dedicated, loyal, and constantly improving workforce.

To nurture this internal “family,” GENTIS organizes annual events such as Year-End Party, Lunar New Year outings, annual trips, comprehensive health checkups, company birthdays, and more, fostering unity and a strong, cohesive team.

Future direction: Continuous innovation – continuous quality improvement

Regarding future development, Mr. Do Manh Ha stated that Eurofins – GENTIS has clearly defined goals:

Complete CAP certification across all tests and labs nationwide
Expand advanced testing services to support diagnosis and treatment
Strengthen research collaboration with domestic and international partners
Upgrade the Ho Chi Minh City laboratory to international standards and expand networks across the country
Most importantly, continuously improve service quality so that clients experience not only precise results but also warmth and care from every GENTIS staff member

15 years – leading and growing

Fifteen years may not be a long journey, but it has firmly placed GENTIS on Vietnam’s genetic medicine map, leaving a lasting impression on customers, partners, and the community. GENTIS is proud to have accompanied families in tracing their roots, infertile couples on their journey to parenthood, and protecting the health of future generations.

GENTIS will continue to advance with Vietnamese heart, Vietnamese intellect, and international standards, committed to constantly improving services to meet global benchmarks in genetic and genomic testing.

[content_more] => [meta_title] => GENTIS 15 Years – sowing aspirations, reaping trust [meta_description] => On October 26, 2010, a small milestone was marked in the field of biomedical science in Vietnam: GENTIS – the first genetic testing center in Hanoi – was founded. [meta_keyword] => [thumbnail_alt] => [post_id] => 1376 [category_id] => 4 ) [3] => stdClass Object ( [id] => 1375 [id_crawler] => [category_product] => NULL [thumbnail] => my205757.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2025-10-26 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-10-28 08:46:10 [updated_time] => 2025-10-29 09:41:21 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => GENTIS-15-years-of-creating-value-for-public-health [title] => GENTIS – 15 years of creating value for public health [description] => On the evening of October 25, 2025, in the beautiful coastal city of Ha Long, GENTIS Genetic Analysis Services Joint Stock Company (GENTIS) solemnly held its 15th Anniversary Celebration (October 26, 2010 – October 26, 2025) in a warm, heartfelt, and highly emotional atmosphere. [content] =>

The event served as an opportunity for all employees, customers, and partners to reflect on the proud journey so far while fueling motivation to move forward toward the future with unwavering belief and ambition.

A Milestone journey – 15 years of steady progress

Since its founding in 2010, GENTIS has continuously grown and established a leading position in the field of genetic analysis in Vietnam. With a long-term vision, sustainable development strategy, and a high-quality workforce, GENTIS has become a pioneering symbol in applying genetic technology for healthcare.

Over the past 15 years, the journey has been full of effort and challenges, yet marked by remarkable achievements:

Expanding a nationwide genetic testing network
Collaborating with many prestigious international partners in genetics
Strong investment in infrastructure and internationally standardized laboratories
Continuously improving customer service quality

GENTIS has played an important role in modernizing Vietnamese medicine through the application of advanced genetic testing solutions for diagnosis, treatment, and disease prevention.

A warm, emotional, and memorable celebration

Held in one of the country’s most famous tourist destinations – Ha Long, the anniversary celebration was not only a milestone event but also an occasion for everyone to share, express gratitude, and connect. The ceremony began with a commemorative photo session of the leadership board, employees, and guests. The space was vibrant with colors, dazzling lights, and cheerful laughter, creating a cozy start to a grand event.

Following that, the audience enjoyed lively performances organized and performed by GENTIS members themselves. Heroic songs and graceful dances not only showcased artistic talent but also reflected the spirit of unity, creativity, and enthusiasm – hallmarks of GENTIS culture.

Highlights of the event

One of the most touching moments of the ceremony was the speech by Mr. Đo Manh Ha – CEO of GENTIS. He recounted the company’s 15-year journey of relentless effort and expressed heartfelt gratitude to all employees, partners, and customers – those who have accompanied, continue to accompany, and will accompany GENTIS in its mission to serve public health.

Mr. Đo Manh Ha also reaffirmed the company’s strategic vision for the next phase, in which GENTIS will continue to:

Invest heavily in genetic technology research and development
Expand international collaborations
Innovate services to provide optimal customer experiences
Develop a comprehensive genetic ecosystem for the Vietnamese people

One of the most impressive moments was the recognition of employees with 5, 10, and 15 years of service. These are the people who have devoted themselves to building GENTIS into the strong company it is today. Each name called, each bouquet presented, each warm embrace brought happiness, pride, and a sense that their contributions are always valued.

Following the recognition ceremony was the most meaningful moment: the leadership and management team raised their glasses and cut the birthday cake, officially marking GENTIS’s 15th anniversary. The cake, designed with the GENTIS logo in hopeful green and pure white, symbolized a firm belief in the company’s bright future.

This moment was not only a summary of a remarkable journey but also the starting point for the paths ahead, where GENTIS will continue to grow, innovate, and serve the health of millions of Vietnamese people.

Looking ahead

The 15th-anniversary celebration was not only a time to reflect on the past but also a strong affirmation that GENTIS will not stop here.

With a strategic vision, modern technology foundation, and talented workforce, GENTIS continues to develop a comprehensive genetic ecosystem with outstanding services such as family testing, non-invasive prenatal testing (NIPT), pre-marital and prenatal genetic counseling, and other genetic tests.

GENTIS’s growth is not only a corporate achievement but also a source of pride for Vietnamese medicine in its integration with global trends in personalized healthcare.

15 years – A journey of trust, value, and leadership

For GENTIS, this is just the beginning of an even brighter journey ahead. Once again, congratulations to GENTIS on its 15th anniversary! Wishing the company continued growth and to remain a trusted companion for millions of Vietnamese families in caring for and protecting health through genetic science.

[content_more] => [meta_title] => GENTIS – 15 years of creating value for public health [meta_description] => On the evening of October 25, 2025, in the beautiful coastal city of Ha Long, GENTIS Genetic Analysis Services Joint Stock Company (GENTIS) solemnly held its 15th Anniversary Celebration (October 26, 2010 – October 26, 2025) in a warm, heartfelt, and high [meta_keyword] => [thumbnail_alt] => [post_id] => 1375 [category_id] => 4 ) [4] => stdClass Object ( [id] => 1374 [id_crawler] => [category_product] => NULL [thumbnail] => 565146852_1222653929882222_4756649354324039800_n_(1).jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 1 [displayed_time] => 2025-10-28 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-10-28 08:27:20 [updated_time] => 2025-10-28 10:10:27 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => GENTIS-honored-to-welcome-CAP-expert-delegation-at-headquarters-Hanoi [title] => GENTIS honored to welcome CAP expert delegation at headquarters - Hanoi [description] => On October 17, 2025, GENTIS had the honor of welcoming a delegation of senior experts from the College of American Pathologists (CAP) – the world’s leading organization in clinical laboratory accreditation – to visit and work at its headquarters in Hanoi. [content] =>

This visit marks a significant milestone, underscoring the strong and enduring partnership between GENTIS and CAP in maintaining and advancing international quality standards for laboratory testing in Vietnam. It also provided an opportunity for both parties to engage in in-depth discussions on sustainable development strategies and future cooperation directions, contributing to the growth of Vietnam’s genetic testing industry to regional and global levels.

The CAP delegation included senior leaders with extensive experience in laboratory science and international market development. Among them were Ms. Xiaocong (Angra) Wang, Regional Leader for Southeast Asia, South Asia, and Oceania; Ms. Elizabeth Tudor, Senior Leader in Global Support and Development; Mr. Sean Harrington, Director of International Market Development; and Mr. Brian Nowlin, Vice President of International Market Development at CAP. The participation of these distinguished experts brought valuable insights, strategic perspectives, and collaboration opportunities for advancing testing standards in Vietnam.

During the working session, the CAP delegation and GENTIS leadership, along with its technical team, exchanged knowledge and international experience in laboratory quality management. They also shared strategic perspectives on developing efficient operational models aimed at transparency and standardization in accordance with CAP standards. The delegation directly visited the PGT and NIPT laboratories, both of which achieved CAP accreditation in June 2025—an important milestone affirming GENTIS’s commitment to quality and credibility.

The College of American Pathologists (CAP) is one of the most prestigious organizations in the world for medical laboratory accreditation and inspection, recognized in over 100 countries. Achieving CAP accreditation means that a laboratory meets the most stringent requirements for operational processes, personnel competence, and test result accuracy. Therefore, GENTIS’s attainment of this certification is not only a source of pride but also clear evidence of its continuous efforts to ensure world-class service quality.

During the visit, the CAP delegation highly commended GENTIS for its investment in modern equipment, strict adherence to quality management procedures, and development of a highly qualified workforce. GENTIS’s achievements in implementing CAP standards reaffirm its professional expertise and pioneering position in the field of genetic testing.

GENTIS is committed to providing laboratory testing services that are accurate, safe, and transparent. Its continuous efforts to maintain, strengthen, and expand international standards such as CAP demonstrate GENTIS’s strong commitment to quality and sustainable development.

The visit and working session with the CAP delegation not only recognized GENTIS’s accomplishments but also opened new avenues for potential collaboration in the future. With a solid foundation of expertise, technology, and human resources, GENTIS continues to affirm its leading position in genetic testing in Vietnam and contributes to the advancement of modern medicine in the region.

[content_more] => [meta_title] => GENTIS honored to welcome CAP expert delegation at headquarters - Hanoi [meta_description] => On October 17, 2025, GENTIS had the honor of welcoming a delegation of senior experts from the College of American Pathologists (CAP) – the world’s leading organization in clinical laboratory accreditation – to visit and work at its headquarters in Hanoi. [meta_keyword] => GENTIS [thumbnail_alt] => [post_id] => 1374 [category_id] => 4 ) [5] => stdClass Object ( [id] => 1373 [id_crawler] => [category_product] => NULL [thumbnail] => 565773600_1223544959793119_2949476054075220034_n.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 1 [displayed_time] => 2025-10-27 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-10-27 16:45:28 [updated_time] => 2025-10-28 10:38:29 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => GENTIS-welcomes-CAMMED-Medical-Laboratory-for-a-visit-and-collaboration-expanding-international-cooporation-for-public-health [title] => GENTIS welcomes CAMMED Medical Laboratory for a visit and collaboration – expanding international cooperation for public health [description] => On October 18, 2025, at its headquarters in Hanoi, GENTIS Genetic Analysis Services Joint Stock Company proudly welcomed a delegation from CAMMED Medical Laboratory (Cambodia) for a visit and collaborative discussions. The visit marked an important milestone in GENTIS’s international cooperation journey, aiming to bring advanced genetic testing technologies closer to communities across Southeast Asia. [content] =>

The CAMMED delegation included members of the Board of Directors, laboratory management, and the business department, led by Ms. Koem Sivfin – Business Director. On the GENTIS side, Mr. Nguyen Manh Ha – CEO, Mr. Pham Dinh Minh – R&D Director, and Ms. Hang Le – International Cooperation Coordinator, attended the meeting.

During the session, GENTIS representatives provided an overview of the company’s operations, professional capabilities, internationally accredited laboratory systems, and advanced genetic testing technologies such as PGT and NIPT.

The CAMMED delegation expressed deep admiration for GENTIS’s modern facilities, rigorous quality control processes, and highly experienced team of experts. Both sides discussed trends in the regional genetic testing industry, shared operational experiences, and explored potential cooperation in training, technology transfer, and applied research.

One key topic of discussion was the plan to expand NIPT services in Cambodia. Drawing from successful implementation in Vietnam, GENTIS shared operational models, professional workflows, and quality assurance standards, enabling CAMMED to develop effective and sustainable prenatal screening services in Cambodia.

Additionally, GENTIS introduced its PGT service – preimplantation genetic testing, an advanced reproductive solution that helps select healthy embryos before in vitro fertilization (IVF). This service is expected to be implemented soon by CAMMED, providing opportunities for many families facing infertility.

The CAMMED delegation also toured GENTIS’s state-of-the-art laboratories and met partner clinics in Hanoi, learning about the connection model between GENTIS and domestic healthcare facilities – an essential foundation for applying this model in the Cambodian market.

The meeting took place in a friendly, professional, and open atmosphere. Both sides affirmed that cooperation between GENTIS and CAMMED goes beyond business interests, reflecting a shared commitment to providing accurate, safe, and humane genetic testing solutions for the benefit of public health in Southeast Asia.

Ms. Koem Sivfin of CAMMED expressed sincere gratitude for GENTIS’s warm reception and expressed confidence that both sides would soon implement multiple concrete collaborative projects.

The visit and working session of CAMMED Medical Laboratory affirmed GENTIS’s prestige, expertise, and influence in the field of genetic testing in Vietnam and the region. It provides an important foundation for GENTIS to continue expanding international cooperation and, together with regional partners, to spread the value of advanced medical science and technology, aiming for comprehensive and sustainable public health care.

[content_more] => [meta_title] => GENTIS welcomes CAMMED Medical Laboratory for a visit and collaboration – expanding international co [meta_description] => On October 18, 2025, at its headquarters in Hanoi, GENTIS Genetic Analysis Services Joint Stock Company proudly welcomed a delegation from CAMMED Medical Laboratory (Cambodia) for a visit and collaborative discussions. [meta_keyword] => GENTIS [thumbnail_alt] => [post_id] => 1373 [category_id] => 4 ) [6] => stdClass Object ( [id] => 1372 [id_crawler] => [category_product] => NULL [thumbnail] => 565102005_1221798849967730_2421886531515618477_n.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2025-10-22 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-10-22 13:36:34 [updated_time] => 2025-10-28 10:24:37 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => Screening-and-dianostic-test-panel-for-male-infertility-Experience-from-Eurofins-GENTIS-labolatory [title] => Screening and diagnostic test panel for male infertility: Experience from Eurofins - GENTIS laboratory [description] => Male infertility is a sensitive topic that is sometimes overlooked during infertility consultations. However, in reality, it accounts for nearly 50% of infertility cases among couples. While women are often evaluated early, many men are not diagnosed in time, leading to delayed treatment or even the selection of inappropriate assisted reproductive methods. [content] =>

In response to this reality, Eurofins - GENTIS has developed a comprehensive testing panel aimed at accurately screening and diagnosing the causes of male infertility. This panel not only helps doctors identify the root causes but also allows for individualized treatment plans, optimizing the chances of conception for couples.

Medical research shows that male infertility can arise from multiple causes: about 70% result from testicular defects, 15% are related to endocrine disorders, 5% involve sperm motility issues, and 10% remain unexplained. Notably, genetic factors are implicated in approximately 15% of male infertility cases. These factors may include chromosomal abnormalities, gene mutations, or epigenetic disorders, which cannot be detected using standard tests. Early detection of these genetic factors is crucial not only for accurately assessing spermatogenic potential but also for preventing the transmission of genetic disorders to future generations through controlled assisted reproductive methods such as IVF combined with PGT-M.

Dr. Vu Thu Huong (GENTIS) presented on genetic causes of male infertility at the VSSM 2025 Conference

Therefore, the process of evaluating male infertility follows a standardized protocol in line with recommendations from the European Association of Urology (EAU, 2025), the American Society for Reproductive Medicine (ASRM), and expert consensus. First, all men suspected of infertility undergo a thorough medical history review and clinical examination to evaluate relevant parameters.

The goal of the initial assessment is to identify cases that can be treated or couples with male-factor infertility who may benefit from assisted reproductive interventions. Depending on the results, further investigations may be conducted, such as testicular ultrasound to detect conditions like hydrocele or varicocele—common but treatable causes if detected early. Physicians may also order endocrine and extended tests, particularly genetic tests, to identify the underlying cause of infertility.

Semen analysis is the first and fundamental test for evaluating sperm quality. It measures sperm concentration, motility, and morphology. If abnormalities are found, the test is typically repeated after 2–3 weeks to rule out temporary factors such as stress, acute illness, or environmental influences. Additionally, endocrine evaluation through FSH, LH, and testosterone levels helps differentiate primary versus secondary hypogonadism, especially in cases with very low sperm counts (<5 million/mL).

Karyotype testing is a key genetic test performed at Eurofins - GENTIS. It is indicated for patients with azoospermia or severe oligozoospermia (sperm count <5 million/mL) to detect numerical or structural chromosomal abnormalities, such as Klinefelter syndrome (47,XXY) or chromosomal deletions and translocations. This allows physicians to provide prognosis regarding spermatogenic potential and guide appropriate treatment.

Dr. Huong shared various screening and diagnostic tests for male infertility

Another common genetic cause of male infertility is microdeletions in the AZF region of the Y chromosome, which is the second most frequent genetic factor after chromosomal abnormalities. AZFa, AZFb, and AZFc regions contain genes essential for spermatogenesis, and deletions in these areas can directly cause infertility. Testing is indicated for azoospermic men or those with sperm counts below 5 million/mL, and is mandatory for counts below 1 million/mL. Identifying deletions in AZFa or AZFb is crucial because affected patients typically lack spermatogenic potential, preventing unnecessary interventions, while AZFc deletions may still allow for sperm retrieval and assisted reproduction. This test also plays a role in genetic counseling, as Y chromosome deletions in the father can be inherited by sons via ICSI.

Another cause of obstructive male infertility is congenital absence of the vas deferens (CBAVD), commonly associated with CFTR gene mutations causing cystic fibrosis. Men with low semen volume (<1 mL), acidic semen (pH <7.0), and absent sperm, along with relevant clinical history, are tested for CFTR mutations. At GENTIS, this test uses PCR combined with Sanger sequencing to detect 22 common CFTR mutations, including variants like Val470Met and Arg117His, as well as IVS8 polymorphisms. Results allow physicians to identify CBAVD-related infertility and plan treatments such as vas deferens reconstruction, testicular sperm extraction, or IVF/ICSI, while providing genetic counseling to prevent cystic fibrosis in offspring.

Beyond basic genetic tests, sperm DNA fragmentation (SDF) testing is an important tool in diagnosing male infertility, particularly in unexplained infertility, recurrent miscarriage, or repeated IVF/ICSI failure. At GENTIS, SDF is performed using the SCSA method, which employs specialized fluorescent dyes and flow cytometry to assess sperm DNA damage. Based on SDF results, physicians can recommend lifestyle modifications (e.g., quitting smoking, weight loss, reducing environmental toxin exposure, antioxidant supplementation) or interventions such as varicocele repair or advanced sperm selection techniques like PICSI or MACS to improve treatment outcomes.

Dr. Huong discussed the benefits of genetic testing in male infertility screening and diagnosis

At the 2025 National VSSM Scientific Conference, MSc. Dr. Vu Thu Huong (R&D Specialist at GENTIS) noted that in 30–40% of cases, even after all standard tests, the cause of infertility remains unknown. Next-generation sequencing (NGS) offers a breakthrough by analyzing large panels of genes related to spermatogenesis, identifying rare or novel mutations. Targeted gene panels or whole exome sequencing (WES) can determine molecular-level causes. However, incidental findings or variants of uncertain significance (VUS) may complicate counseling and treatment decisions. GENTIS has a team of genetic experts capable of multidisciplinary consultation and international database review to provide personalized guidance.

Dr. Huong emphasized that not every patient requires genetic testing; it should be performed only with clear clinical indications. Selecting the appropriate test prevents unnecessary interventions, accurately identifies the cause of infertility, enables individualized treatment, informs the choice of assisted reproduction methods, guides PGT-M if needed, and most importantly, reduces risk for future generations.

With over 15 years of experience in genetic testing, Eurofins - GENTIS is a pioneer in Vietnam in applying genetic diagnostics to male infertility. Beyond being a laboratory, GENTIS collaborates with doctors, fertility centers, and patients to make precise, individualized treatment decisions, ultimately helping couples achieve their dream of parenthood safely and sustainably.

[content_more] => [meta_title] => Screening and diagnostic test panel for male infertility: Experience from Eurofins - GENTIS laborato [meta_description] => Male infertility is a sensitive topic that is sometimes overlooked during infertility consultations. [meta_keyword] => GENTIS,PGT [thumbnail_alt] => [post_id] => 1372 [category_id] => 4 ) [7] => stdClass Object ( [id] => 1371 [id_crawler] => [category_product] => NULL [thumbnail] => 3721ee01d0e65db804f7.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2025-10-22 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-10-22 13:23:10 [updated_time] => 2025-10-28 10:06:32 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => Hanoi-mother-overwhelmed-with-emotion-after-finding-her-daugter-in-France-thanks-to-Dantri-newspaper [title] => Hanoi Mother Overwhelmed with Emotion After Finding Her Daughter in France Thanks to Dan Tri Newspaper [description] => Thanks to the active involvement of Dan Tri newspaper, Mrs. La Thi Hong has found her daughter La Thi Hong Hanh (known by her French name, Léa) — who was adopted to France 31 years ago. [content] =>

At 5 p.m., while diligently sweeping the street in Ha Dong Ward, Mrs. La Thi Hong (an environmental worker living in Hanoi) received a special call from GENTIS informing her that the DNA test results confirmed a mother-child biological relationship between her and the girl Léa living in France.

Tears streamed down the weathered face of a woman who has lived more than half her life burdened by the guilt of abandoning her newborn daughter. Looking at the numbers on the DNA test report, Mrs. Hong could hardly believe it was true.

Since learning about her daughter, Mrs. Hong had been anxious and sleepless, waiting for the day of the DNA test. “After 31 years, I feel relieved knowing that my abandoned daughter is living a happy life in Europe. I sincerely thank Dan Tri newspaper for bringing me the greatest happiness in my life,” Mrs. Hong shared.

Previously, Léa had sent samples of her hair and fingernails to Vietnam for the DNA test. On the morning of October 17, Mrs. Hong went to the GENTIS testing center in Hanoi to have her blood sample taken to verify the biological relationship with the girl whose information matched her story.

The Ending After 31 Years of Torment

In June, Mrs. Hong contacted Dan Tri to ask for help finding her daughter, who had been adopted to France.

In 1992, Mrs. Hong fell in love with a young man from a neighboring village. After a year of dating, she found herself unexpectedly pregnant. However, the young man coldly denied responsibility.

After many sleepless nights filled with tears, she decided to keep the baby and raise the child alone, despite the village gossip. On January 2, 1994, the baby girl was born and named La Thi Hong Hanh. Being a single mother with difficult circumstances, Mrs. Hong left her daughter at an orphanage in Soc Sơn.

A few months later, filled with regret, she returned to find her child but was told by the caretaker that the baby had been adopted by a family in France. Mrs. Hong sadly returned to her hometown, carrying the burden of guilt for more than 30 years.
“Back then, having a child out of wedlock was a serious issue in the village. If people were more open-minded like now, I would never have abandoned my daughter,” she said, choking with emotion.

After the article “The tragic life of a Hanoi mother, 31 years searching for her abandoned daughter” was published, Dan Tri reporters contacted several organizations in France to search for the girl La Thi Hong Hanh.

Thanks to their active efforts, within two weeks, Dan Tri found a young woman named Léa living in Montreuil — about 10 km from Paris — whose information matched the story Mrs. Hong described. “Looking at her photo, I noticed she has many facial features similar to mine. In the following days, I was anxious and restless, hoping the DNA test results would match,” she said.

Mrs. Hong shared that she did not expect the search to proceed so quickly. A few years ago, she had thought about finding her daughter but didn’t know where to start.

For many years, only her family and close friends knew she had given birth to a daughter before marrying her current husband. When the story was widely shared, most people sympathized with her. However, some neighbors expressed doubt about her conscience, which made her feel hurt.

Although Léa’s birth date and full name on the documents perfectly matched the story from 31 years ago, Mrs. Hong did not want to expect too much, having hoped before but ended up disappointed.

Mrs. Hong had her blood sample taken for DNA testing at the center.

Two years ago, a girl from France came to Mrs. Hong’s village looking for her biological mother. Upon hearing the news, Mrs. Hong took leave from work and hurried to Thanh Oai (Hanoi), firmly believing the reunion was near. However, after matching information, the girl was not La Thi Hong Hanh. “At that time, it felt like the world had collapsed. I had high hopes but ended up with a bitter disappointment. Still, over the years, I have kept the faith that one day I would meet my daughter again,” she said.

Since receiving the DNA test results, Mrs. Hong’s life has returned to normal. At night, she has trouble sleeping from overwhelming joy and excitement, eagerly waiting for the day to reunite with her daughter.

For 31 years, she has never had a full night’s sleep. The memory of leaving her daughter at the orphanage remains an unending regret. Fortunately, her husband has always understood and is willing to accompany her on the journey to find their daughter.

“I’m not searching for money or material things. I just want to know how she is living and hope my daughter will forgive my past mistakes,” she said.

Currently, Mrs. Hong lives with her husband in a small house on Chinh Kinh street, Hanoi. They have one daughter who is now married.

Her husband suffered a stroke when he was young, so the economic burden has long rested on her shoulders. Life is not wealthy, but Mrs. Hong actively does charity work, hoping to atone in some way for past mistakes.

“After receiving the test results, I hope to hold my daughter in my arms even once, that would be enough. Whether she forgives me or not, I am ready to accept,” she said.

No Resentment Over the Past

Two days after receiving the DNA test results sent by Dan Tri to France, Léa was still overwhelmed with emotion. For more than 30 years, she never imagined a day she would see her biological mother’s image.

“I want to meet my mother but need a little more time to believe this is not a dream,” Léa shared.

According to Léa, her adoptive parents took her from Hanoi back to Paris in 1994. From childhood, she grew up in a loving family in France, receiving full care both materially and emotionally. They never hid the fact that Léa was adopted.

“When I was little, I wished one day to reunite with my family in Vietnam but was afraid my birth mother wouldn’t want to meet me. Since I turned 30, I decided not to search for any information about my origins to avoid getting hurt,” she said.

Léa said she hopes to soon return to Vietnam to visit and meet her biological mother. She had traveled to Vietnam with her adoptive parents when she was 10 years old. To this day, beautiful memories of Hanoi, Ha Long Bay, and the Mekong Delta remain vivid in her mind.

“I would like to thank Dan Tri newspaper and GENTIS testing center for helping my mother and me find each other after many years apart. This is a major turning point in my life,” Léa said.

“A drop of blood is worth more than a pond of water” — this saying has never grown old. In the age of technology, finding lost relatives might seem impossible, but with science and humanity, nothing is impossible.

GENTIS is proud to accompany people on this journey — the journey of bringing people back to their families, reuniting children with their mothers, and bringing smiles back to faces that once bore the pain of separation.

Because above all, every DNA test is not just a result — it is an opportunity for love to be restored.

[content_more] => [meta_title] => Hanoi Mother Overwhelmed with Emotion After Finding Her Daughter in France Thanks to Dan Tri Newspap [meta_description] => Thanks to the active involvement of Dan Tri newspaper, Mrs. La Thi Hong has found her daughter La Thi Hong Hanh (known by her French name, Léa) — who was adopted to France 31 years ago. [meta_keyword] => GENTIS [thumbnail_alt] => [post_id] => 1371 [category_id] => 4 ) )

Eurofins GENTIS accompanies the 25th Vietnam–France obstetrics and gynecology conference (2025)

Amid the dynamic collaboration between Vietnam and France in the field of medicine, the 25th Vietnam–France Obstetrics and Gynecology Conference will officially take place on November 9–10, 2025, in Hanoi. This prestigious annual scientific event in obstetrics and gynecology is hosted by the National Hospital of Obstetrics and Gynecology (NHOG) in collaboration with the French National College of Gynecologists and Obstetricians (CNGOF).

GENTIS welcomes the delegation from Orienda International hospital

On November 1, 2025, Eurofins GENTIS had the honor of welcoming a delegation from Orienda International Hospital (Phnom Penh, Cambodia) to visit and work at the company headquarters. The visit was part of an international cooperation program designed to enhance professional exchange, share experiences, and expand development opportunities in reproductive medicine and laboratory testing between the two organizations.

GENTIS 15 Years – sowing aspirations, reaping trust

On October 26, 2010, a small milestone was marked in the field of biomedical science in Vietnam: GENTIS – the first genetic testing center in Hanoi – was founded. Few knew that from this modest beginning, a 15-year journey of perseverance and dedication to the mission “Enhancing the Physical and Intellectual Health of Vietnamese People” would unfold, built on trust, knowledge, and resilience to overcome every challenge.

GENTIS – 15 years of creating value for public health

On the evening of October 25, 2025, in the beautiful coastal city of Ha Long, GENTIS Genetic Analysis Services Joint Stock Company (GENTIS) solemnly held its 15th Anniversary Celebration (October 26, 2010 – October 26, 2025) in a warm, heartfelt, and highly emotional atmosphere.

GENTIS honored to welcome CAP expert delegation at headquarters - Hanoi

On October 17, 2025, GENTIS had the honor of welcoming a delegation of senior experts from the College of American Pathologists (CAP) – the world’s leading organization in clinical laboratory accreditation – to visit and work at its headquarters in Hanoi.

GENTIS welcomes CAMMED Medical Laboratory for a visit and collaboration – expanding international cooperation for public health

On October 18, 2025, at its headquarters in Hanoi, GENTIS Genetic Analysis Services Joint Stock Company proudly welcomed a delegation from CAMMED Medical Laboratory (Cambodia) for a visit and collaborative discussions. The visit marked an important milestone in GENTIS’s international cooperation journey, aiming to bring advanced genetic testing technologies closer to communities across Southeast Asia.

Screening and diagnostic test panel for male infertility: Experience from Eurofins - GENTIS laboratory

Male infertility is a sensitive topic that is sometimes overlooked during infertility consultations. However, in reality, it accounts for nearly 50% of infertility cases among couples. While women are often evaluated early, many men are not diagnosed in time, leading to delayed treatment or even the selection of inappropriate assisted reproductive methods.

Hanoi Mother Overwhelmed with Emotion After Finding Her Daughter in France Thanks to Dan Tri Newspaper

Thanks to the active involvement of Dan Tri newspaper, Mrs. La Thi Hong has found her daughter La Thi Hong Hanh (known by her French name, Léa) — who was adopted to France 31 years ago.